Le Lézard
Classified in: Health
Subjects: WOM, LGB, NTA, CFG, DEI

Renewed and ongoing supports for families of missing and murdered Indigenous women, girls and 2SLGBTQI+ people


OTTAWA, ON, Feb. 23, 2023 /CNW/ - Support line for those affected by missing and murdered Indigenous women, girls and 2SLGBTQI+ people:

There is a national, toll-free 24/7 crisis call line providing mental health support for anyone who requires emotional assistance related to missing and murdered Indigenous women, girls and 2SLGBTQI+ people. For assistance, call 1-844-413-6649. Supports are also available through the MMIWG2S+ health and cultural support services. Support could include professional counselling with a focus on healing, emotional supports such as listening and referrals to additional services, and culturally specific help centred around traditional healing methods and Elder services.

Today, the Honourable David Lametti, Minister of Justice and Attorney General of Canada, issued the following statement:

"Violence against Indigenous women, girls, and Two-Spirit, Lesbian, Gay, Bisexual, Transgender, Queer, Intersex, Plus (2SLGBTQI+) people in Canada is an ongoing national tragedy that needs to end. Ensuring safety and increasing access to culturally grounded, community-led victim supports for families of missing and murdered Indigenous women, girls and 2SLGBTQI+ people (MMIWG2S+) is a priority for the Government of Canada, along with ensuring that community-based organizations have the tools they need to deliver responsive services for families of MMIWG2S+.

"Today, I am proud to confirm our commitment to renew and provide ongoing support for Family Information Liaison Units (FILUs), so they can continue to deliver critical services to families of MMIWG2S+ across the country. With this support, FILUs will become a permanent resource for Indigenous families in search of information on their missing or murdered loved ones.

"Having up-to-date and accurate information about a missed or murdered loved one plays a significant role in a family member's healing journey. We know there continues to be systemic, structural and geographic barriers for family members as they seek the information they need. FILUs work with families of MMIWG2S+ to overcome those barriers and ensure that they have all the available information they are seeking from various justice agencies and other sectors, as well as access to all other available supports they may require. Their work is critical to those families in need of answers, support, and healing. 

"Since their establishment in 2016, FILUs helped thousands of family members across the country. We know the need for answers has not ended, and we are committed to supporting the continued delivery of their critical supports and services for as long as they are needed."

Quick Facts
Associated Links
Stay Connected

SOURCE Department of Justice Canada


These press releases may also interest you

at 16:20
Verastem Oncology, , a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it intends to offer and sell shares of its common stock and accompanying warrants to purchase shares of common stock,...

at 16:20
Geron Corporation , a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that Anil Kapur, Executive Vice President, Corporate Strategy and Chief Commercial Officer, will depart...

at 16:15
Exelixis, Inc. announced today that its second quarter 2024 financial results will be released on Tuesday, August 6, 2024 after the markets close. At 5:00 p.m. ET / 2:00 p.m. PT, Exelixis management will host a conference call and webcast to discuss...

at 16:15
Nuvation Bio Inc. , a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced multiple updates for its taletrectinib program. Data from the global, pivotal Phase 2 TRUST-II study...

at 16:15
The Board of Directors of BD (Becton, Dickinson and Company) , a leading global medical technology company, today announced it has declared a quarterly dividend of $0.95 per common share, payable on September 30, 2024 to holders of record on...

at 16:05
Ligand Pharmaceuticals Incorporated today announced that it will report second quarter 2024 financial results after the close of the U.S. financial markets on Tuesday, August 6, 2024, and will hold a conference call at 4:30 p.m. Eastern Time that...



News published on and distributed by: